The current valuation score of InflaRx NV is 6.70, ranking 298 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.20, which is -67.05% below the recent high of -1.05 and -245.49% above the recent low of -11.06.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.